* Histogen Inc HSTO.OQ reported a quarterly adjusted loss
of 10 cents per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 17 cents per
share.
* Revenue was $5.00 thousand; analysts expected zero.
* Histogen Inc's reported EPS for the quarter was a loss of 10
cents.
* The mean earnings estimate of analysts had fallen by
about 13.3% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Histogen Inc shares had fallen by 20.5% this quarter and
gained 14.3% so far this year.
* The company reported a quarterly loss of $3.7 million.
* Wall Street's median 12-month price target for Histogen Inc is
$4.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated August 11 at 09:15 p.m. All
figures in US dollars unless otherwise stated